News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke Yael L. Maxwell October 28, 2016
News Daily News La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes Yael L. Maxwell October 28, 2016
News Daily News Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke Shelley Wood May 25, 2016